MENU
CHRS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Coherus BioSciences (CHRS) Ownership - Who owns Coherus BioSciences?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
333 Twin Dolphin Drive
Phone
+1 650 649-3530
Employees
306
Web
https://www.coherus.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
179.73M
P/E Ratio
N/A
Total Cash
97.69M
Projected Growth
N/A
Total Debt
269.88M
Revenue
304.34M
Risk (Beta)
0.65
Dividend Yield
N/A
Total Cash/Share
0.85
Total Debt/Equity
N/A
Revenue/Share
2.48 USD as % of share price
Fundamentals
CHRS
Capitalization
180M
P/E Ratio
N/A
Risk (Beta)
0.65
Dividend Yield
N/A
Total Cash
97.7M
Total Cash/Share
0.85
Total Debt
270M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
2.48%
Revenue
304M
ROE
N/A
Book Value
-87.97M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-0.05
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
12K
Current Ratio
1.25
Current Revenue Per Employee
301165.97
Dividends Per Share - Security
N/A
EBITDA
37.3M
Float
N/A
Float - Current
N/A
Gross Income Margin
70.69
Revenue To Assets
-0.08
Shares Held By Institutions
183M
Shares Outstanding - Current
115M
Total Liabilities
593M
Total Volume MTD
N/A
Value
-1
Gain YTD
-48.649
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a maker of biologic therapeutics for oncology and inflammatory diseases
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
333 Twin Dolphin Drive
Phone
+1 650 649-3530
Employees
306
Web
https://www.coherus.com